Apixaban clinical trials antithrombotics

Eliquis - BMS-562247 - BMS562247 - BMS 562247

Recap Results Trial description old Pinterest treatment           Z

Acute coronary syndrome

All ACS (including AMI):  4 trials  - APPRAISE 2 - APPRAISE-1 (10mg od) - APPRAISE-1 (2.5 mg bid) - APPRAISE japan

All type of patients:  4 trials  - APPRAISE 2 - APPRAISE-1 (10mg od) - APPRAISE-1 (2.5 mg bid) - APPRAISE japan

Patients with a recent ACS:  4 trials  - APPRAISE 2 - APPRAISE-1 (10mg od) - APPRAISE-1 (2.5 mg bid) - APPRAISE japan

Atrial fibrillation

All type of patients :  3 trials  - ARISTOTLE - AVERROES - phase 2 apixaban

Patients ineligible for warfarin:  1 trials  - AVERROES

Primary prevention of thromboembolic events:  3 trials  - ARISTOTLE - AVERROES - phase 2 apixaban

Pulmonary embolism

3 trials  - AMPLIFY - AMPLIFY-EXT 2.5mg - AMPLIFY-EXT 5mg

Thrombosis prevention

elective major knee surgery :  3 trials  - ADVANCE 2 - ADVANCE-1 - APROPOS 2.5mg

All type of patients :  4 trials  - ADVANCE 2 - ADVANCE 3 - ADVANCE-1 - APROPOS 2.5mg

Elective hip replacement:  1 trials  - ADVANCE 3

Elective major knee surgery :  2 trials  - ADVANCE 2 - APROPOS 2.5mg

Medical patients:  1 trials  - ADOPT

Orthopaedic surgery:  4 trials  - ADVANCE 2 - ADVANCE 3 - ADVANCE-1 - APROPOS 2.5mg

Orthopedic surgery :  4 trials  - ADVANCE 2 - ADVANCE 3 - ADVANCE-1 - APROPOS 2.5mg

Patients with cancer:  1 trials  - CV185-027

Venous thrombosis

secondary prevention of VTE :  2 trials  - AMPLIFY-EXT 2.5mg - AMPLIFY-EXT 5mg

All type of patients:  4 trials  - AMPLIFY - AMPLIFY-EXT 2.5mg - AMPLIFY-EXT 5mg - Botticelli DVT

All types of patients:  4 trials  - AMPLIFY - AMPLIFY-EXT 2.5mg - AMPLIFY-EXT 5mg - Botticelli DVT